Financials
- Market Capitalization 11.18 B
- Employee 3 100
- Founded 1976
- CEO Charles R. Kummeth
- Website www.bio-techne.com
- Headquarter Minnesota, United States
- FIGI BBG000C15114
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
75.74
Relación precio/flujo de caja
6.8
Dividendos por acción
0.08
Rendimiento por dividendo, %
1.07
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 823 | SMMT Summit Therapeutics Inc. - Common Stock | 15.49 USD | +0.13% | -2.21% | +9.70% | -22.00% | 12.02 B USD | ||
| 848 | BMRN BioMarin Pharmaceutical Inc. - Common Stock | 58.64 USD | 0.00% | -2.07% | +5.37% | +2.99% | 11.33 B USD | ||
| 879 | ABVX Abivax SA - American Depositary Shares | 135.84 USD | +0.69% | -3.67% | +37.21% | +1255.69% | 10.67 B USD | ||
| 907 | CYTK Cytokinetics, Incorporated - Common Stock | 81.21 USD | -0.88% | -4.38% | +11.25% | +39.78% | 10.11 B USD |